In the Media
-
The LogicTop Prospects: Leading innovators from the Class of 2024
School of Engineering graduate Liam Krebbers was recognized for his academic excellence.
-
Study International3 universities paving the way for future international architects
UBC's SALA was recognized as one of three schools paving the way for future international architects.
-
Techcouver.comCleantech startup launches out of UBC with specialized carbon fibre innovation
Materials Engineering Assistant Professor Dr. Yasmine Abdin and Bioproducts Institute (BPI)'s Dr. Frank Ko are deploying techniques to create sub-micron fibres.
-
UBC Research + InnovationApplied Science-led projects awarded over $8.7M from NSERC 2024 Discovery Research Program
Forty faculty members from SCARP and Engineering received funding on 41 different projects on transportation planning, the clean energy transition, and more.
-
CBC NewsResearchers working to develop device to detect, treat brain cancer
ECE professor Dr. Konrad Walus is part of the research team that received a two-year grant from the Tri-Agency New Frontiers in Research Fund.
-
Daily CourierSchool of Engineering graduates remember the COVID years
SOE graduate Liam Krebbers comments on his high-school graduation during COVID-19 compared to his recent graduation from UBCO.
-
UBC Research + InnovationUBC Applied Science-led research receives over $2 million in funding from NFRF
Researchers from UBC Engineering, SALA and SCARP are leading interdisciplinary teams tackling climate change mitigation and community solutions.
-
Kelowna Capital NewsOkanagan university students build autobot to sniff out ‘zombie’ fires
UBCO School of Engineering students have created an autobot that can detect underground wildfires that can smoulder unnoticed for months.
-
UBC News$140 million for UBC-led research hub to accelerate drug development and biomanufacturing
SBME Assistant Professor Dr. Anna Blakney co-leads the project AVENGER, an end-to-end drug development platform for RNA vaccines, based at UBC. The AVENGER team will create a library of vaccine formulations that can be custom designed and rapidly deployed against pandemic pathogens and other diseases.
-
The Globe and MailBC drug developers get boost with government funding for new manufacturing facility
SBME Assistant Professor Dr. Anna Blakney co-leads the project AVENGER, an end-to-end drug development platform for RNA vaccines, based at UBC. The AVENGER team will create a library of vaccine formulations that can be custom designed and rapidly deployed against pandemic pathogens and other diseases.